We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$54.9M
2
IMCR icon
Immunocore
IMCR
+$48.2M
3
ARKK icon
ARK Innovation ETF
ARKK
+$41.6M
4
TWTR
Twitter, Inc.
TWTR
+$36.7M
5
RNAM
Avidity Biosciences
RNAM
+$29.2M

Top Sells

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$23.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$19M
3
RBAC
RedBall Acquisition Corp.
RBAC
+$12.5M
4
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$12.1M
5
STOK icon
Stoke Therapeutics
STOK
+$11.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LWLG icon
701
Lightwave Logic
LWLG
$1.16B
– –
-56,000
Closed -$366K
MBI icon
702
CALL
MBIA
MBI
$253M
– –
-22,500
Closed -$10K
MBI icon
703
PUT
MBIA
MBI
$253M
– –
-9,400
Closed -$6K
MGK icon
704
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.6B
– –
-14,725
Closed -$535K
MGV icon
705
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.6B
– –
-5,590
Closed -$538K
MLTX icon
706
MoonLake Immunotherapeutics
MLTX
$1.41B
– –
-16,173
Closed -$85K
MO icon
707
CALL
Altria Group
MO
$109B
– –
-141,900
Closed -$47K
MRK icon
708
CALL
Merck
MRK
$322B
– –
-12,300
Closed -$42K
MRNA icon
709
CALL
Moderna
MRNA
$24.2B
– –
-6,400
Closed -$3K
MRNA icon
710
PUT
Moderna
MRNA
$24.2B
– –
-16,300
Closed -$5.04M
MRVL icon
711
Marvell Technology
MRVL
$191B
– –
-25,000
Closed -$1.09M
MSFT icon
712
CALL
Microsoft
MSFT
$3.74T
– –
-30,000
Closed -$20K
MSFT icon
713
Microsoft
MSFT
$3.74T
– –
-500
Closed -$128K
MSFT icon
714
PUT
Microsoft
MSFT
$3.74T
– –
-5,000
Closed -$11K
MSOS icon
715
PUT
AdvisorShares Pure US Cannabis ETF
MSOS
$930M
– –
-126,000
Closed -$173K
MTAL
716
DELISTED
Metals Acquisition
MTAL
– –
-415,855
Closed -$4.07M
MTZ icon
717
CALL
MasTec
MTZ
$21.9B
– –
-20,000
Closed -$34K
MTZ icon
718
PUT
MasTec
MTZ
$21.9B
– –
-20,000
Closed -$14K
MX icon
719
CALL
Magnachip Semiconductor
MX
$142M
– –
-84,100
Closed -$40K
MX icon
720
PUT
Magnachip Semiconductor
MX
$142M
– –
-21,000
Closed -$13K
NOK icon
721
Nokia
NOK
$52.7B
– –
-1,000,000
Closed -$4.61M
NVDA icon
722
CALL
NVIDIA
NVDA
$5.27T
– –
-50,000
Closed -$3K
NVDA icon
723
NVIDIA
NVDA
$5.27T
– –
-100,000
Closed -$1.52M
NVDA icon
724
PUT
NVIDIA
NVDA
$5.27T
– –
-200,000
Closed -$180K
PACB icon
725
CALL
Pacific Biosciences
PACB
$354M
– –
-60,600
Closed -$9K
27 28
29
30 31

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.